Modular Medical - התחייבויות לטווח ארוך של החברה MODD

This daily price chart for Modular Medical (MODD) reflects metrics at 0.00. Modular Medical is developing the MODD1, an affordable and user-friendly automated insulin delivery system. The business relies on third-party contractors for assembly and service to maintain a strategic focus on R&D. However, relying on a single product during the development stage entails significant regulatory and manufacturing risks.

Investors are assessing business resilience through the volume of liabilities with maturities exceeding one year, which determines the company's ability to service loans without liquidity risk. An analysis of the long-term financial debt structure of Modular Medical (MODD) reveals the extent to which the company utilizes leverage to fund the development of the MODD1 pump and scale its expansion into the diabetes device market by 2026.